The mission of this unit is to develop processes to move basic science discoveries towards translation into research in humans. We provide guidance in the development of Investigational New Drug (IND) applications. We identify and pursue opportunities to develop progressive capacities for in vitro, ex vivo, in vivo and in silico approaches for evaluating new pharmaceutical and therapeutic agents.
The mission of this unit is to assist with the development of clinical research projects as well as transitioning clinical trials from Phase I to Phase II and to Phase III. We develop marketing plans, standard operating procedures (SOPs), personnel training plans and policies to guide all clinical research.
The mission of this unit is to develop, coordinate, and facilitate research activities and translation between clinical and community/population research stages.